Cargando…
Recent developments in biomarkers in Parkinson disease
PURPOSE OF REVIEW: Parkinson disease is the second most common neurodegenerative disease after Alzheimer disease, and current demographic trends indicate a life-time risk approaching 4% and predict a doubling of prevalence by 2030. Strategies are being developed to apply recent advances in our under...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196782/ https://www.ncbi.nlm.nih.gov/pubmed/23823465 http://dx.doi.org/10.1097/WCO.0b013e3283633741 |